U.S. flag

An official website of the United States government

NM_000138.5(FBN1):c.989-1G>C AND Marfan syndrome

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Nov 16, 2023
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000664040.2

Allele description [Variation Report for NM_000138.5(FBN1):c.989-1G>C]

NM_000138.5(FBN1):c.989-1G>C

Genes:
LOC113939944:Sharpr-MPRA regulatory region 9539 [Gene]
FBN1:fibrillin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
15q21.1
Genomic location:
Preferred name:
NM_000138.5(FBN1):c.989-1G>C
HGVS:
  • NC_000015.10:g.48520818C>G
  • NG_008805.2:g.129971G>C
  • NG_063729.1:g.387C>G
  • NM_000138.5:c.989-1G>CMANE SELECT
  • NM_001406716.1:c.989-1G>C
  • LRG_778t1:c.989-1G>C
  • LRG_778:g.129971G>C
  • NC_000015.9:g.48813015C>G
  • NM_000138.4:c.989-1G>C
Links:
dbSNP: rs1555400616
NCBI 1000 Genomes Browser:
rs1555400616
Molecular consequence:
  • NM_000138.5:c.989-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001406716.1:c.989-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]

Condition(s)

Name:
Marfan syndrome (MFS)
Synonyms:
MARFAN SYNDROME, TYPE I; Marfan syndrome type 1; Marfan's syndrome; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007947; MedGen: C0024796; Orphanet: 284963; Orphanet: 558; OMIM: 154700

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000787435Center for Medical Genetics Ghent, University of Ghent
no assertion criteria provided
Pathogenic
(Nov 7, 2017)
germlineclinical testing

SCV004123030ClinGen FBN1 Variant Curation Expert Panel, ClinGen
reviewed by expert panel

(Assertion Criteria VCEP FBN1 Version 1)
Pathogenic
(Nov 16, 2023)
germlinecuration

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration

Details of each submission

From Center for Medical Genetics Ghent, University of Ghent, SCV000787435.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From ClinGen FBN1 Variant Curation Expert Panel, ClinGen, SCV004123030.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

NM_00138 c.989-1G>C in FBN1 is a splice site variant predicted to affect an acceptor splice site in intron 8 of the gene. Experimental cDNA sequencing studies have demonstrated that this variant disrupts mRNA splicing, causing the in-frame deletion of exon 9 and resulting in abnormal protein product (PVS1_strong; PMID: 15241795). This variant was found in one proband (reported twice in the literature) meeting the revised Ghent criteria for clinical diagnoses of Marfan syndrome (PP4; PMIDs: 15241795, 24161884); in one family, the variant was found to segregate with features of Marfan syndrome in at least 10 family members (PP1_strong; PMID: 15241795This variant has been reported 1 time in ClinVar as pathogenic (Variation ID: 549476). It is not present in gnomAD (PM2_supporting; https://gnomad.broadinstitute.org/). In summary, this variant meets criteria to be classified as pathogenic for Marfan syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen FBN1 VCEP: PVS1_strong, PP1_strong, PM2_supporting, PP4.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 25, 2023